» Articles » PMID: 15618221

TTK/hMps1 Participates in the Regulation of DNA Damage Checkpoint Response by Phosphorylating CHK2 on Threonine 68

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Dec 25
PMID 15618221
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

CHK2/hCds1 plays important roles in the DNA damage-induced cell cycle checkpoint by phosphorylating several important targets, such as Cdc25 and p53. To obtain a better understanding of the CHK2 signaling pathway, we have carried out a yeast two-hybrid screen to search for potential CHK2-interacting proteins. Here, we report the identification of the mitotic checkpoint kinase, TTK/hMps1, as a novel CHK2-interacting protein. TTK/hMps1 directly phosphorylates CHK2 on Thr-68 in vitro. Expression of a TTK kinase-dead mutant, TTK(D647A), interferes with the G(2)/M arrest induced by either ionizing radiation or UV light. Interestingly, induction of CHK2 Thr-68 phosphorylation and of several downstream events, such as cyclin B1 accumulation and Cdc2 Tyr-15 phosphorylation, is also affected. Furthermore, ablation of TTK expression using small interfering RNA results not only in reduced CHK2 Thr-68 phosphorylation, but also in impaired growth arrest. Our results are consistent with a model in which TTK functions upstream from CHK2 in response to DNA damage and suggest possible cross-talk between the spindle assembly checkpoint and the DNA damage checkpoint.

Citing Articles

TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma.

Longo L, Hughes T, McNeil-Laidley B, Cottini F, Hilinski G, Merritt E Haematologica. 2023; 109(2):578-590.

PMID: 37496433 PMC: 10828771. DOI: 10.3324/haematol.2023.282838.


Mettl14-mediated mA modification ensures the cell-cycle progression of late-born retinal progenitor cells.

Li L, Sun Y, Davis A, Shah S, Hamed L, Wu M Cell Rep. 2023; 42(6):112596.

PMID: 37269288 PMC: 10543643. DOI: 10.1016/j.celrep.2023.112596.


Minor Kinases with Major Roles in Cytokinesis Regulation.

Sechi S, Piergentili R, Giansanti M Cells. 2022; 11(22).

PMID: 36429067 PMC: 9688779. DOI: 10.3390/cells11223639.


Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors.

Ashraf N, Asari A, Yousaf N, Ahmad M, Ahmed M, Faisal A Front Chem. 2022; 10:1003816.

PMID: 36405310 PMC: 9666879. DOI: 10.3389/fchem.2022.1003816.


Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.

Erol A Cancer Manag Res. 2022; 14:2339-2356.

PMID: 35958947 PMC: 9362849. DOI: 10.2147/CMAR.S373557.